CROSARA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 1.104
EU - Europa 836
AS - Asia 462
SA - Sud America 12
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.419
Nazione #
US - Stati Uniti d'America 1.094
CN - Cina 281
IT - Italia 247
IE - Irlanda 190
SE - Svezia 156
SG - Singapore 73
TR - Turchia 63
FI - Finlandia 60
DE - Germania 49
AT - Austria 29
FR - Francia 24
GB - Regno Unito 21
BE - Belgio 20
IR - Iran 19
UA - Ucraina 14
IN - India 12
BR - Brasile 11
HU - Ungheria 6
TW - Taiwan 6
JP - Giappone 5
NL - Olanda 5
CA - Canada 4
MX - Messico 4
CH - Svizzera 3
CI - Costa d'Avorio 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
EE - Estonia 2
HN - Honduras 2
NO - Norvegia 2
QA - Qatar 2
A1 - Anonimo 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
RO - Romania 1
Totale 2.419
Città #
Chandler 207
Dublin 190
Ashburn 111
Ann Arbor 109
Beijing 71
Boardman 64
Izmir 61
Chicago 60
Dearborn 58
Nanjing 45
Singapore 45
Parma 41
Princeton 36
Milan 28
Shanghai 27
Vienna 25
Los Angeles 24
Wilmington 22
Bremen 20
Shenyang 20
Brussels 19
Kunming 14
Hebei 13
Sant'ilario D'enza 12
Mountain View 11
San Mateo 11
Santa Clara 11
Fremont 10
Jacksonville 10
London 10
Changsha 9
Helsinki 9
Jinan 9
Nanchang 9
Woodbridge 9
Zanjan 9
New York 8
Jiaxing 7
Monza 7
São Paulo 7
Brescia 6
Des Moines 6
Hefei 6
Ningbo 6
Pignone 6
Vicopisano 6
Washington 6
Abano Terme 5
Bougligny 5
Genoa 5
Preston City 5
Seattle 5
Zhengzhou 5
Chengdu 4
Düsseldorf 4
Guangzhou 4
Hangzhou 4
Munich 4
Rome 4
Sassuolo 4
Verona 4
Abidjan 3
Bari 3
Chieti 3
Dallas 3
Frankfurt am Main 3
Haikou 3
Leawood 3
Magenta 3
Marabá 3
Mexico City 3
Mumbai 3
New Taipei 3
Norwalk 3
Pune 3
Sacramento 3
San Lazzaro di Savena 3
Tianjin 3
Tokyo 3
Trapani 3
Vaiano Cremasco 3
Wake Forest 3
Berlin 2
Bologna 2
Borås 2
Brno 2
Casanova Lonati 2
Catania 2
Doha 2
Fuzhou 2
Giessen 2
Houston 2
Lodi 2
Lviv 2
Montreal 2
Nonantola 2
Oslo 2
Paderno Dugnano 2
Padova 2
Palermo 2
Totale 1.671
Nome #
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 153
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 153
Transthoracic echocardiography in clinically healthy adult Newfoundland dogs: reference values for the breed 104
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 102
Tetralogia di Fallot in un gatto 90
Systolic Arterial Pressure Measured Simultaneously by Doppler Technique, Using Forelimb and Hindlimb in Dogs 89
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 84
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 83
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease 81
Migration of a Kirschner wire to the heart in a Yorkshire terrier 71
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 70
ECG of the month 64
Anatomic distribution and electrophysiologic properties of accessory atrioventricular pathways in dogs 59
Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease 59
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 57
Corner Diagnostico di Cardiologia 55
Miocardiopatie del cane 53
Screening for subaortic stenosis in Boxers in Italy 53
Endocardite batterica 52
Holter monitoring in 36 dogs with myxomatous mitral valve disease 51
Diagnostic performance of P wave duration in the identification of left atrial enlargement in dogs 50
Insufficienza cardiaca: fisiopatologia e principi di terapia 48
Malattia cronica mitralica 48
La malattia valvolare mitralica nel cane 48
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease 48
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 47
The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics 47
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 46
Radiofrequency catheter ablation of concealed accessory pathways in two dogs with symptomatic atrioventricular reciprocating tachycardia 46
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 46
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 44
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 41
Holter monitoring in dogs with mitral regurgitation and different class of heart failure 40
Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration 39
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 39
Use of contrast echocardiography for quantitative and qualitative evaluation of myocardial perfusion and pulmonary transit time in healthy dogs 37
Utility of 12-Lead Electrocardiogram for Differentiating Paroxysmal Supraventricular Tachycardias in Dogs 36
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease 36
Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats 33
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs 33
Effect of the sampling time on urinary electrolytes following furosemide administration in dogs with myxomatous mitral valve disease 17
Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease 14
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 12
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 11
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 5
Bradyarrhythmia after treatment with atenolol and mirtazapine in a cat with hypertrophic cardiomyopathy 3
Totale 2.497
Categoria #
all - tutte 10.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020250 0 0 17 9 17 57 36 24 19 59 8 4
2020/2021142 3 8 12 5 23 13 4 15 29 17 7 6
2021/2022231 33 5 6 14 11 2 6 26 7 15 33 73
2022/2023833 68 84 60 68 69 89 12 63 253 21 24 22
2023/2024466 29 33 23 17 35 97 24 42 22 39 18 87
2024/2025160 51 49 60 0 0 0 0 0 0 0 0 0
Totale 2.497